Search

Search Results
Results 3381 - 3390 of 8422 for allergy
  • Drug - 27 Jun 2024
    Consumer Medicine Information (CMI) about Itracap intended for persons living in Australia.
  • News - 26 Jun 2024
    The injectable antiretroviral drug lenacapavir was safe and 100% effective as long-acting HIV pre-exposure prophylaxis (PrEP) among cisgender women in a Phase 3 clinical trial, according to top-line...
  • Drug - 8 Feb 2024
    Consumer Medicine Information (CMI) about Lozanoc intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Mayne Pharma Erythromycin intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Eryc intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Ilevro (Nepafenac 0.3%) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Invanz intended for persons living in Australia.
  • News - 24 Jan 2024
    In an analysis of all relevant published studies that assessed atopic dermatitis (also known as eczema) associated with trends in climate-related hazards due to greenhouse gas emissions, investigators...
  • News - 30 Nov 2023
    Pranay Sinha, MD, assistant professor of medicine at Boston University Chobanian & Avedisian School of Medicine, has received a National Institutes of Health Mentored Research Scientist Development...
  • News - 20 Sep 2023
    A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.